Difference between revisions of "Zhu Z, et al. Int. J. Cancer (2010) cited as Ref 709 in DOI: 10.1038/s41392-020-0110-5 (Q9972)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 126, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Cancer stem/progenitor cells are highly enriched in CD133(+)CD44(+) population in hepatocellular carcinoma, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Cancer stem/progenitor cells are highly enriched in CD133(+)CD44(+) population in hepatocellular carcinoma (English) | ||
| Property / title: Cancer stem/progenitor cells are highly enriched in CD133(+)CD44(+) population in hepatocellular carcinoma (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:07, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zhu Z, et al. Int. J. Cancer (2010) cited as Ref 709 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zhu Z
0 references
2010
0 references
Int. J. Cancer
0 references
126
0 references
Cancer stem/progenitor cells are highly enriched in CD133(+)CD44(+) population in hepatocellular carcinoma (English)
0 references
